MyFinsight
Home
Blog
About
Back
Cash Flow
MAIA Biotechnology, Inc. (MAIA)
MAIA Biotechnology, Inc. (MAIA)
source: myfinsight.com
Net increase in cash
-$6,817,279
(-1354.97%↓ Y/Y)
Stock-based compensation
$723,915
(-38.34%↓ Y/Y)
Prepaid expenses and
other current assets
-$264,876
(-175.19%↓ Y/Y)
Restricted stock issued for
consulting expense
$198,936
Accrued expenses
$80,749
(-91.94%↓ Y/Y)
Change in fair value of
warrant liability
$69,829
(112.35%↑ Y/Y)
Net cash used in
operating activities
-$6,750,055
(19.04%↑ Y/Y)
Net cash provided by
financing activities
-$65,000
(-100.73%↓ Y/Y)
Net effect of
foreign currency...
-$2,224
(-119.46%↓ Y/Y)
Canceled cashflow
$1,338,305
Net loss
-$7,943,587
(19.47%↑ Y/Y)
Payment of offering
transactions costs
$65,000
(-82.95%↓ Y/Y)
Accounts payable
-$144,773
(-170.27%↓ Y/Y)
Back